STAR

STRIDES PHARMA Q4 ; EX U.S BIZ OUTLOOK; Other Regulated Markets Expansion of product portfolio and new customer acquisitions to drive growth Conversion of the existing strong funnel of new opportunities to deliver growth Continued momentum in filings will drive growth in the medium term ■ Growth Markets ; Sandoz acquired portfolio to start contributing from H2FY27 onwards Significant regulatory filings in new territories have commenced; however, the regulatory timelines in most markets are longer Focus on portfolio maximization strategies, and astute channel partner expansion will drive the future growth